Figure S3 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

(A) Paired scatter plot demonstrating the correlation between the immune-associated gene expression and PD-L1. (B) PD-L1 immunohistochemistry and mRNA expression in pre-treatment core biopsies. The definition of >= 1 % of positively stained tumor cells is associated with CD274 (=PD-L1) mRNA expression (t-test P-value and area under the curve).